PDA

View Full Version : Medical Articles and Abstracts


Pages : [1] 2 3 4

  1. Bloodless cardiac surgery: not just possible, but preferable.
  2. Current role of bloodless liver resection.
  3. On-line autotransfusion waste calculator
  4. Short-term ferrous sulfate supplementation in female blood donors
  5. Efficacy, safety and compliance of intravenous iron sucrose and in anemia/pregnancy
  6. Short-term ferrous sulfate supplementation in female blood donors
  7. Use of Recombinant Factor VIIa in Life-Threatening Obstetric Postpartum Hemorrhage
  8. Adverse outcomes of blood transfusion in children
  9. The role of blood transfusion in the management of upper and lower intestinal tract b
  10. Duration of red-cell storage and complications after cardiac surgery.
  11. Does perioperative use of aprotinin reduce the rejection rate in heart transplant rec
  12. The decrease of preoperative autologous transfusion in France has not been linked to
  13. Changes in transfusion practice for surgery.
  14. Erythropoiesis-stimulating agents and other methods to enhance oxygen transport.
  15. Laparoscopic Cortical-Sparing Adrenalectomy for Bilateral Pheochromocytoma.
  16. ENT surgery, blood and Jehovah's Witnesses.
  17. Successful autologous peripheral blood stem cell transplantation in a JW...
  18. Ruptured heterotopic interstitial pregnancy: rare case... in a JW patient
  19. Acute normovolemic hemodilution... in a JW with placenta percreta.
  20. Anemia Drugs for Cancer Patients Increase Death Risk
  21. Blood Management: A Primer for Clinicians
  22. Legal & Ethical Considerations in Transfusion of Infected or Untested Autologous Bloo
  23. Blood conservation strategies to reduce the need for red blood cell transfusion in...
  24. Transfusion-related acute lung injury: a clinical challenge
  25. Cell salvage in obstetrics
  26. Blood conservation strategies to reduce need red blood cell transfusion critical ill
  27. Case report: Transfusion-related acute lung injury (TRALI) A clear and present danger
  28. Blood transfusion associated with increased resource utilisation, cadiac surgery
  29. Aprotinin is safe in pediatric patients undergoing cardiac surgery.
  30. Novel erythropoiesis-stimulating agents: a new era in anemia management.
  31. Increased risk of infection and mortality in women after cardiac surgery related...
  32. The ideal transfusion trigger in critically ill patients
  33. Tranexamic acid reduces blood transfusion in total knee arthroplasty even when a bloo
  34. Prevalence of hepatitis C virus infection at start of hemodialysis in Japan.
  35. Transfusion-related acute lung injury (TRALI) A clear and present danger
  36. A Jehovah's Witness child with hemophilia B... undergoing scoliosis surgery
  37. Foreign blood saving measures in orthopedic surgery
  38. Studies Probe Weaknesses in Donated Blood
  39. Voluven Helps Minimize Surgical Blood Loss
  40. Pathophysiology of TRALI: current concepts.
  41. Am J Respir Crit Care Med.
  42. Experience of a network of transfusion coordinators for blood conservation
  43. Increased mortality, postoperative morbidity, and cost after red blood cell ...
  44. Anemia and Transfusions in Patients Undergoing Surgery for Cancer.
  45. Effect of early blood transfusion on gastrointestinal haemorrhage
  46. Adverse effects of transfusion
  47. Effect of blood transfusion on outcome after major burn injury: a multicenter study
  48. A simple technique ligating the corresponding inflow and outflow vessels during an...
  49. Hemorrhage from DIC controlled by Factor VIIa
  50. Transfusion Alert for Patients with Curable Cancer
  51. Association of Red Cell Transfusion with Mortality in Patients with Acute Lung Injury
  52. Estimating the cost of blood: past, present, and future directions.
  53. Blood conservation in the critically ill.
  54. Impact of blood loss on outcome after liver resection.
  55. Bloodless (Liver) Surgery? The Anesthetist's View.
  56. Pediatric cardiac surgery without homologous blood transfusion, using a ...
  57. The pathogenesis of transfusion-related acute lung injury (TRALI).
  58. West Nile virus adheres to human red blood cells in whole blood.
  59. Anemia Management and Blood Conservation in the Hospital Setting
  60. Improved coagulation and blood conservation in the golden hours after cardiopulmonary
  61. Stored Packed Red Blood Cell Transfusion Up-regulates Inflammatory . . .
  62. Results of major hepatectomy without vascular clamping . . .
  63. The role of recombinant factor VIIa in on-pump cardiac surgery: Proceedings
  64. Verses, viruses, and the vulnerability of the blood supply in industrialized countrie
  65. BleedingWeb.com's Free Slide Shows
  66. Aprotinin in orthotopic liver transplantation: evidence for a prohemostatic, but not
  67. Transfusion-transmitted infection in hemophilia in developing countries.
  68. Products for clotting factor replacement in developing countries.
  69. Efficacy of recombinant factor VIIa administered by continuous infusion to haemophili
  70. NovoSeven: mode of action and use in acquired haemophilia.
  71. Antidotes to haemorrhage: recombinant factor VIIa.
  72. Incidence of symptomatic deep venous thrombosis with epoetin alfa or darbepoetin alfa
  73. Cost-effectiveness of cell salvage and alternative methods of minimising perioperativ
  74. Clinical review -Autologous transfusion.
  75. Blood transfusion medicine
  76. Eliminating Blood Transfusions: New Aspects and Perspectives
  77. Risks, benefits, alternatives and indications of allogenic blood transfusions.
  78. Live Donor Liver Transplantation Without Blood Products
  79. Pre-operative high or low red blood cell count linked with poorer outcomes older pats
  80. Treatments for iron-deficiency anaemia in pregnancy.
  81. Milk iron content in breast-feeding mothers after administration of intravenous iron
  82. A dose exploration, phase I/II study of administration of continuous erythropoietin r
  83. Addition of intravenous iron to epoetin beta increases hemoglobin response and decrea
  84. Clinical update: intravenous iron for anaemia.
  85. Preoperative use of recombinant human erythropoietin in pediatric orthopedics: a...
  86. Mortality associated with aprotinin during 5 years following coronary artery bypass g
  87. Effect of recombinant aprotinin on postoperative blood loss and coronary vascular fun
  88. Impact of aspirin with or without clopidogrel on postoperative bleeding and blood tra
  89. Perioperative blood transfusion and blood conservation in cardiac surgery: the Soc...
  90. Association of Red Cell Transfusion with Mortality in Patients with Acute Lung Injury
  91. Blood conservation techniques in obstetrics: a UK perspective
  92. Study Questions Risks of Anti-Bleeding Drug during Heart Surgery - Hartford Hospital
  93. Clinical Guidelines for Blood Conservation During Cardiac Procedures Developed
  94. An economic analysis of costs associated with development of a cell salvage program.
  95. Transfusion Strategies for Patients in Pediatric Intensive Care Units
  96. Minimally invasive cardiopulmonary bypass: does it really change the outcome?
  97. An economic analysis of costs associated with development of a cell salvage program
  98. Fresh frozen plasma and platelet transfusions are associated with . . .
  99. s resuscitation from hemorrhagic shock limited by blood oxygen-carrying . . .
  100. Erythropoietin and iron-restricted erythropoiesis.
  101. Paroxysmal Nocturnal Hemoglobinuria
  102. Prevention and Management of Postpartum Hemorrhage
  103. Management of bleeding following major trauma: a European guideline
  104. Mortality associated with aprotinin during 5 years following coronary artery bypass..
  105. Addition of intravenous iron to epoetin beta increases hemoglobin response and dec...
  106. Residual risk of transfusion-transmitted viral infections in Shenzhen, China, 2001...
  107. Effects of a Restrictive Blood Transfusion Policy on Outcomes in Children With Burn I
  108. Effects of a Restrictive Blood Transfusion Policy on Outcomes in Children With Burn
  109. Budget impact analysis of a blood saving program for urgent traumatological surgery
  110. [Haemorrhage and transfusion: the peculiar case of Jehovah's witnesses]
  111. Thrombotic thrombocytopenic purpura induced by trimethoprim-sulfamethoxazole in a Jeh
  112. Speed of haemoglobin response in patients with cancer: a review of the erythropoietic
  113. Thromboembolic adverse events after use of recombinant human coagulation factor VIIa.
  114. Recombinant activated factor VII as an adjunctive therapy for bleeding control trauma
  115. The effects of normal as compared with low hematocrit values in patients with cardiac
  116. Improved survival with higher hematocrits: where is the evidence?
  117. Early versus late erythropoietin for preventing red blood cell transfusion in preterm
  118. The Premature Infants in Need of Transfusion (PINT) study
  119. Anemia - More Aggressive Identification And Treatment Needed To Improve Outcomes
  120. Aggressive Anemia Treatment Increases Mortality
  121. Thromboembolic adverse events after use of recombinant human coagulation factor VIIa
  122. Prevalence of HIV-1 in blood donations following implementation of a structured ...
  123. Evaluation of anaemia in patients with multiple myeloma and lymphoma: findings of ...
  124. Effect of low central venous pressure and phlebotomy on blood product transfusion . .
  125. Intraoperative Red Blood-Cell Salvage in Revision Hip Surgery
  126. Transfusion Risks and Transfusion-related Pro-inflammatory Responses
  127. Risk and prevention of transfusion-related sepsis
  128. Bacterial contamination of platelet units
  129. Bacterial contamination of blood products.
  130. Bacterial contamination of blood components: risks, strategies, and regulation
  131. Effect of repeated intravenous iron administration in haemodialysis patients
  132. The use of erythropoietin in patients undergoing radical prostatectomy: effects . . .
  133. Clinical approaches involving thrombopoietin to shorten the period of thrombocytop...
  134. Evaluation of anaemia in patients with multiple myeloma and lymphoma: findings of...
  135. Anemia - Erythropoietin
  136. How we manage requests for recombinant factor VIIa (NovoSeven).
  137. Hemodilutional anemia impairs neurologic outcome after cardiopulmonary bypass in a...
  138. Transfusion-associated microchimerism: a new complication of blood transfusions in...
  139. The use of hemostatic agents and sealants in urology.
  140. Red cell substitutes.
  141. Blood transfusions are associated with increased risk for development of sepsis...
  142. Pilot Study of Low-tech Garment to Prevent Maternal Death from Postpartum Hemorrhage
  143. Transfusion-related acute lung injury and pulmonary edema in critically ill...
  144. Cell Salvage: Ultrafiltration reduces blood transfusions following cardiac surgery...
  145. Determinants of complications with recombinant factor VIIa for refractory blood loss
  146. Anesthesia Techniques: Effect of low central venous pressure and phlebotomy on blood
  147. Transfusion Practice: Allogeneic blood transfusions explain increased mortality in wo
  148. Changing indications for red cell transfusion from 2000 to 2004 in the North of Engla
  149. Intravenous Iron - Determination of VIT 45 (IND#63,243 - American Regent) removal by
  150. Effect of high- and low-molecular-weight low-substituted hydroxyethyl starch on blood
  151. Ultrafiltration reduces blood transfusions following cardiac surgery: a meta-analysis
  152. Aprotinin; friend or foe? A review of recent medical literature.
  153. Latest Advances in Surgical Adhesives and Sealants
  154. Genomics and blood substitutes for 21st century Europe ("EuroBloodSubstitutes").
  155. The Efficacy Of Ugu (Telfaira Occidentals) In The Management of Childhood Anemia:
  156. Resuscitation Of A Jehovah's Witness With Multiple Injuries Without Blood:
  157. Advance Directives: Many Critically Ill Patients Lack
  158. Failure to adopt beneficial therapies caused by bias in medical evidence evaluation
  159. Improved preoperative iron status assessment by soluble transferrin receptor in elder
  160. New approaches to the management of anemia of chronic kidney disease: Beyond Epogen a
  161. Safe and successful restriction of transfusion in burn patients.
  162. Egg on their Faces
  163. MIT material stops bleeding in seconds
  164. Effects of a combined therapy of erythropoietin, iron, folate, and vitamin B12 on the
  165. Perioperative intravenous iron preserves iron stores and may hasten the recovery from
  166. Evaluation of anaemia in patients with multiple myeloma and lymphoma: findings of the
  167. The use of erythropoietin in patients undergoing radical prostatectomy: effects on he
  168. Cost-effectiveness of cell salvage and alternative methods of minimising perioperativ
  169. Should plasma be transfused prophylactically before invasive procedures?
  170. Resistance of viruses to inactivation in blood products
  171. Surgical site infection following bowel surgery: a retrospective analysis of 1446 pat
  172. The effects of leukoreduced blood transfusion on infection risk following injury: a r
  173. Use of the Hemobag for Modified Ultrafiltration in a Jehovah’s Witness Patient Underg
  174. Significant reduction in blood loss in patients undergoing minimal extracorporeal cir
  175. A novel erythropoietic agent
  176. Intraoperative blood salvage with blood irradiation -- from an anaesthesiological poi
  177. The use of antifibrinolytic agents in total hip arthroplasty: a meta-analysis
  178. Derivation of a risk index for the prediction of massive blood transfusion in liver t
  179. Impact of a transfusion-free program on non-Jehovah's Witness patients undergoing liv
  180. Assessing the total costs of blood delivery to hospital oncology and haematology pati
  181. A prospective, randomized platelet-function study of heparinized oxygenators and card
  182. The Premature Infants in Need of Transfusion (PINT) study: a randomized, controlled t
  183. Preoperative epoetin alfa vs autologous blood donation in primary total knee arthropl
  184. Influence of hemoglobin levels on inpatient rehabilitation outcomes after total knee
  185. Utilization of platelet transfusions in the intensive care unit: indications, transfu
  186. Effect of fresh-frozen plasma transfusion on prothrombin time and bleeding in patient
  187. Double-blind, placebo-controlled study of quality of life, hematologic end points, an
  188. The value of an albumin-based intravascular volume replacement strategy in elderly pa
  189. Hypertonic-hyperoncotic solutions improve cardiac function in children after open-hea
  190. Intraoperative red blood cell transfusion during coronary artery bypass graft surgery
  191. Blood transfusion is associated with infection and increased resource utilization in
  192. Determinants of complications with recombinant factor VIIa for refractory blood loss
  193. Recombinant factor VIIa and the surgical patient
  194. Prediction of massive blood transfusion in cardiac surgery
  195. Efficacy of recombinant human erythropoietin in critically ill patients admitted to a
  196. Effect of intravenous ascorbic acid in hemodialysis patients with EPO-hyporesponsive
  197. Red blood cell transfusions and nosocomial infections in critically ill patients
  198. Developing a blood conservation program in cardiac surgery
  199. Perioperative intravenous iron, with or without erythropoietin, plus restrictive tran
  200. The clinical benefits of the leukoreduction of blood products
  201. Effects of cell saver autologous blood transfusion on blood loss and homologous blood
  202. Major hepatectomy in children: approaching blood transfusion-free
  203. A randomized, controlled trial of the effects of adding vitamin B12 and folate to ery
  204. Acute normovolemic hemodilution in moderate blood loss surgery: a randomized controll
  205. Persistent effect of red cell transfusion on health-related quality of life after car
  206. Erythrocyte iron incorporation but not absorption is increased by intravenous iron ad
  207. Iron and the anaemia of chronic disease: a review and strategic recommendations
  208. The association between duration of storage of transfused red blood cells and morbidi
  209. Recombinant human erythropoietins and cancer patients: updated meta-analysis of 57 st
  210. Risks, benefits, alternatives and indications of allogenic blood transfusions
  211. Fresh blood and aged stored blood are equally efficacious in immediately reversing an
  212. Platelet gel and fibrin sealant reduce allogeneic blood transfusions in total knee ar
  213. Epsilon aminocaproic acid reduces transfusion requirements in patients with thrombocy
  214. Transfusion in coronary artery bypass grafting is associated with reduced long-term s
  215. Morbidity and mortality risk associated with red blood cell and blood-component trans
  216. Effect of blood transfusion on outcome after major burn injury: a multicenter study
  217. Does the use of erythropoietin reduce the risk of exposure to allogeneic blood transf
  218. Evidence-based red cell transfusion in the critically ill: quality improvement using
  219. Role of parenteral iron in transfusion requirements after total hip replacement. A pi
  220. Diagnosis and management of iron-related anemias in critical illness
  221. The impact of an hematocrit of 20% during normothermic cardiopulmonary bypass for ele
  222. Comparison of the effects of aprotinin and tranexamic acid on blood loss and red bloo
  223. Red blood cell transfusion practices amongst Canadian anesthesiologists: a survey
  224. Fluid challenge revisited
  225. Intraoperative Blood Salvage in Penetrating Abdominal Trauma: a Randomised, Controlle
  226. A head-to-head comparison of the in vitro coagulation effects of saline-based and bal
  227. The Premature Infants in Need of Transfusion (PINT) study: a randomized, controlled t
  228. Preoperative epoetin alfa vs autologous blood donation in primary total knee arthropl
  229. Influence of hemoglobin levels on inpatient rehabilitation outcomes after total knee
  230. Anemia, transfusion and phlebotomy practices in critically ill patients with prolonge
  231. Role of parenteral iron in transfusion requirements after total hip replacement. A pi
  232. A head-to-head comparison of the in vitro coagulation effects of saline-based and bal
  233. Recombinant activated factor VII in the treatment of near-fatal bleeding during pedia
  234. Prediction of the effect of acute normovolemic hemodilution on the hematological cons
  235. Reduction of postoperative spinal infections based on an etiologic protocol.
  236. Predicting late anemia in critical illness.
  237. Phase III study of two different dosing schedules of erythropoietin in anemic patient
  238. A propensity score case-control comparison of aprotinin and tranexamic acid in high-
  239. Effectiveness of darbepoetin-alfa in combination with intravenous iron sucrose in pat
  240. Local infusion of norepinephrine reduces blood losses and need of transfusion in tota
  241. Recombinant activated factor VII: treating postoperative hemorrhage in cardiac surger
  242. Blood transfusion in critically injured patients: a prospective study.
  243. Blood viscosity maintains microvascular conditions during normovolemic anemia indepen
  244. Perioperative red cell, plasma, and blood volume change in patients undergoing cardia
  245. A prospective study investigating the cost effectiveness of intraoperative blood salv
  246. Cost, quality, and risk: measuring and stopping the hidden costs of coronary artery b
  247. Every 3 weeks dosing with darbepoetin alfa: A new paradigm in anaemia management.
  248. Comparison of lactated Ringer's, gelatine and blood resuscitation on intestinal oxyge
  249. Intraoperative red blood cell transfusion during coronary artery bypass graft surgery
  250. Blood transfusion is associated with infection and increased resource utilization in